Tardive Dyskinesia Movement

Download PDF

Recent Publications on Tardive Dyskinesia Movement:
The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population. Background. Tardive dyskinesia is a serious adverse event, which is...	18th July, 2008	School of Medicine, Western Psychiatric Institute & Clinic and University	Ann Clin Psychiatry. 2008 Jul-Sep;20(3):139-44. DOI Direct Link
Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. OBJECTIVE: Ethnicity is a risk factor for tardive dyskinesia (TD) and...	9th July, 2008	Northern Psychiatry Research Centre and Northern Area Mental Health	Acta Psychiatr Scand. 2008 Jun;117(6):474-8. DOI Direct Link
Drug-induced tardive syndromes. We reviewed the database of five Movement Disorders Units to establish...	2nd July, 2008	Department of Neurology, Hospital Universitario Principe de Asturias,	Parkinsonism Relat Disord. 1999 Apr;5(1-2):59-65.
The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment. Abstract Tardive dyskinesia (TD) is associated with polymorphisms of the...	20th June, 2008	Department of Pharmacotherapy and Pharmaceutical Care, GUIDE, University	J Psychopharmacol. 2008 Jun 18;. DOI Direct Link
Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. OBJECTIVE: The goal of this study was to evaluate the efficacy and safety...	17th June, 2008	Department of Psychiatry, Yale University, Connecticut Mental Health	J Clin Psychiatry. 2008 Apr;69(4):546-54.
→View more research publications.

BioNews Results for Tardive Dyskinesia Movement:
Janssen Announces Launch of Authorized Generic for Risperdal	Pharma Live:  Jul 2 2008 2:32AM Matching: tardive dyskinesia movement
Janssen Announces Launch of Authorized Generic for RISPERDAL(R)	TickerTech.com:  Jun 30 2008 9:49PM Matching: tardive dyskinesia movement

Tardive Dyskinesia Movement Patents:
US Patent No.	Title
7253165	Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D.sub.4 antagonists
5677313	Antipsychotic method
5679686	Antipsychotic method
5750541	Method of treating schizophrenia
5753683	Antipsychotic method
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Tardive Dyskinesia Movement scientists - we have details of around 93 individuals working on Tardive Dyskinesia Movement .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.